• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Comparative effectiveness, safety, and costs of rivaroxaban and warfarin among morbidly obese patients with atrial fibrillation
ConclusionsMorbidly obese AF patients treated with rivaroxaban had comparable risk of ischemic stroke/systemic embolism and major bleeding as those treated with warfarin, but lower healthcare resource utilization and costs.
Source: American Heart Journal - February 21, 2019 Category: Cardiology Source Type: research

Ischemic Cardiac Outcomes and Hospitalizations According to Prior Macrovascular Disease Status in Patients with Type 2 Diabetes and Recent Acute Coronary Syndrome from the EXAMINE trial
Conclusions EXAMINE demonstrates that there was no increase in the risk of cardiac ischemic events and cardiovascular hospitalizations with alogliptin in a high-risk post-ACS patient population. Since these are major driver of overall healthcare costs, these data suggest that there would be no adverse impact on healthcare resource utilization.
Source: American Heart Journal - January 25, 2016 Category: Cardiology Source Type: research